This is a disclosure report regarding financial/non-financial relationships with for-profit/non-profit healthcare organizations.
Pharmaceutical companies with potential conflict of interest
- Honoraria for the last 2 years for attending advisory boards from Pierre Faber, Bayer, Octimet, Clovis Oncology, Novartis, Karus Therapeutics, Biosceptre, BMS, Cybrexa, Ellipses, CV6 Therapeutics, Astex Therapeutics and Sanofi Aventis.
- Honoraria for delivery of educational talks or chairing educational meetings by AstraZeneca, Novartis, Bayer, Tesaro and BMS. I have received funds to support attendance at conferences from BMS and MSD.
Other affiliations with potential conflict of interest
- No partnerships to disclose.
Last updated on 29 May 2020